Organization Overview
Alternative names
Aneurysm (Phase 3)
Arachnodactyly (Phase 3)
beta-Thalassemia (Phase 2)
Cardiomyopathies (Phase 2)
Cardiomyopathy, Hypertrophic (Phase 2)
Cardiovascular Diseases (Phase 3)
Communicable Diseases (Phase 3)
Congenital Abnormalities (Phase 3)
Coronary Aneurysm (Phase 3)
Coronary Disease (Phase 3)
Dyslipidemias (Phase 4)
Heart Defects, Congenital (Phase 3)
Heart Diseases (Phase 3)
Heart Failure (Phase 3)
Heart Septal Defects, Ventricular (Phase 1)
Hemophilia A (Phase 2)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis C (Phase 2)
Hypertension (Phase 3)
Hypertension, Pulmonary (Phase 3)
Hypoplastic Left Heart Syndrome (Phase 2)
Infarction (Phase 3)
Infections (Phase 3)
Ischemia (Phase 3)
Marfan Syndrome (Phase 3)
Mucocutaneous Lymph Node Syndrome (Phase 3)
Myocardial Infarction (Phase 3)
Myocardial Ischemia (Phase 3)
Neutropenia (Phase 3)
Obesity (Phase 4)
Premature Birth (Phase 2)
Premature Ejaculation (Phase 2)
Purpura (Phase 3)
Purpura, Thrombocytopenic (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Purpura, Thrombotic Thrombocytopenic (Phase 3)
Syndrome (Phase 3)
Tetralogy of Fallot (Phase 1)
Thalassemia (Phase 3)
Transposition of Great Vessels (Phase 1)